From yesterdays disclosure.... “The performan
Post# of 148288
(Total Views: 502)
Posted On: 09/02/2020 2:04:11 PM
Re: nmbr1stckpckr #53714
From yesterdays disclosure....
“The performance measure for the performance based restricted stock granted to our executives in 2020 related to the Company achieving FDA Breakthrough Therapy designation for 22 cancer indications within 6 months of the award date. These performance conditions were not achieved, and therefore the performance shares issued to executives in 2020 were forfeited on July 28, 2020”.
6M performance shares ($7.2M) granted to NP in fiscal 2020 were forfeited for non-performance.
The problem I have is we don’t have forward visibility to what the metrics are for 2021. 4.35M of the 8.8M (50%) total incentive shares requested for 2021 are “performance based" restricted. If the performance conditions are similar to those in 2020, they should be meaningful to the shareholders. We just don’t know at this point.
“The performance measure for the performance based restricted stock granted to our executives in 2020 related to the Company achieving FDA Breakthrough Therapy designation for 22 cancer indications within 6 months of the award date. These performance conditions were not achieved, and therefore the performance shares issued to executives in 2020 were forfeited on July 28, 2020”.
6M performance shares ($7.2M) granted to NP in fiscal 2020 were forfeited for non-performance.
The problem I have is we don’t have forward visibility to what the metrics are for 2021. 4.35M of the 8.8M (50%) total incentive shares requested for 2021 are “performance based" restricted. If the performance conditions are similar to those in 2020, they should be meaningful to the shareholders. We just don’t know at this point.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼